MI/26/50_2 Administration Officer

Key Details

Job ID:
MI/26/50_2
Role:
Administration Officer
Area:
Salary:
Circa £32,000 per annum
Closing date:
3rd December 2026

About the role

The Cancer Research UK Manchester Institute is seeking a highly organised, proactive and professional Administration Officer to help ensure the effective and efficient running of the Director’s Office.

Working closely with the Executive Assistant to the Director, you will take ownership of agreed administrative activity, coordination and follow-up. Your contribution will enable the Executive Assistant to focus on strategic diary and inbox management, forward planning, relationship management and the Director’s priorities.

This is a varied and visible role at the centre of the Institute. You will provide the organisational and administrative infrastructure that keeps activity moving, ensures commitments are followed through and supports a consistently high standard of service.

About you

You will bring sound judgement, discretion and a strong sense of ownership. You will be comfortable working at pace, managing changing priorities and following work through to completion while maintaining accuracy and professionalism.

You will have degree-level education or equivalent relevant experience, together with experience of organising and reprioritising a varied workload in a fast-paced environment. Experience of supporting meetings, including preparing papers, taking notes and tracking actions to completion, would be advantageous.

This role requires on-site working to meet operational needs; remote working is not available for this role.

Paterson Building Scientific Administration

More information

About CRUK Manchester Institute

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials. rnThe Institute has access to outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry.

How to apply

To apply for this position please complete the online application via ‘Apply Now’. Please ensure you detail the names of two referees and ensure you submit your application before the closing date specified (03 December 2026).

Please note this vacancy will close for applications at 18:00 on the closing date specified.

Informal enquiries can be directed to Kate Brammer via email: kate.brammer@cruk.manchester.ac.uk

Why choose Cancer Research UK Manchester Institute?

The Cancer Research UK Manchester Institute, an Institute of The University of Manchester, is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org),
the largest independent cancer research organisation in the world.

We are partnered with The Christie NHS Foundation Trust, one of the largest cancer treatment centres in Europe, which is located adjacent to the CRUK MI Manchester Institute in South Manchester. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Careers that have a lasting impact on cancer research and patient care

We are always on the lookout for talented and motivated people to join us.  Whether your background is in biological or chemical sciences, mathematics or finance, computer science or logistics, use the links below to see roles across the Institute in our core facilities, operations teams, research groups, and studentships within our exceptional graduate programme.

Four individuals pose together in a laboratory. They're wearing lab coats each with a Cancer Research UK logo.
An immunofluorescence microscopy image of kidney tissue showing different tissue structures stained in red, blue, and green The blue colour (DAPI) is widespread, indicating the location of cell nuclei throughout the sample. The green colour (LTL) highlights specific regions, indicating the presence of proximal tubule cells. The red colour (NPHS1) is also distinct in certain areas, showing the presence of podocytes in the glomeruli. The overlapping colours in some regions suggest the complex structure and the close association of these different cell types within the kidney.

Latest from CRUK MI

New major support for our lung cancer prevention research

ScottishPower has committed £690,000 to co-fund our Cancer Origins research group with the University of Manchester, enabling investigations into what causes lung cancer to emerge and how we can prevent it.

New publication: Bacteria inside kidney tumors associate with myeloid inflammation and disease progression – A TRACERx Renal study

Research explores the role of intratumour bacteria in disease progression

Read our latest Scientific Report

The latest Scientific Report highlights an incredible year of growth for the Institute and many research successes. We welcomed a new Director, Samra Turajlić to the Institute, and saw the establishment of three new independent research groups.

New major support for our lung cancer prevention research
New publication: Bacteria inside kidney tumors associate with myeloid inflammation and disease progression – A TRACERx Renal study
Read our latest Scientific Report